Randomized Trial: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial – The Lancet (free)

Commentaries: Radiotherapy for newly diagnosed oligometastatic prostate cancer – The Lancet (free) AND ESMO 2018: Local radiotherapy improves survival in metastatic prostate cancer with low disease burden – eCancer News (free) AND Radiotherapy offers hopes in advanced prostate cancer – OnMedica (free) AND Cancer trial shows treating the prostate with radiotherapy improves survival – University of Birmingham (free)